Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects.

N Wodarz1, J Fritze, J Kornhuber

  • 1Department of Psychiatry, University of Würzburg, Germany.

Biological Psychiatry
|February 1, 1992
PubMed
Summary

This study reevaluates 3H-spiroperidol binding to lymphocytes as a schizophrenia marker. Uncontrolled methodological issues, like filter binding and granulocytes, may explain prior controversies regarding this dopamine D2 receptor marker.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sphingolipids in Emotional Well-Being.

Journal of neurochemistry·2026
Same author

[The diamorphine treatment of opioid addicts-On the amendment of the indication criteria according to the narcotics prescription regulation].

Der Nervenarzt·2025
Same author

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study.

Epidemiology and psychiatric sciences·2022
Same author

Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders.

Frontiers in neuroendocrinology·2019
Same author

Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial.

The journal of prevention of Alzheimer's disease·2018
Same author

Epigenetic control of epilepsy target genes contributes to a cellular memory of epileptogenesis in cultured rat hippocampal neurons.

Acta neuropathologica communications·2017

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • 3H-spiroperidol binding to lymphocytes has been suggested as a potential vulnerability marker for schizophrenia.
  • The biological significance and existence of this specific lymphocyte binding site remain controversial, necessitating further investigation.

Purpose of the Study:

  • To reevaluate the methodological details of 3H-spiroperidol binding assays in lymphocytes.
  • To identify and address potential confounding factors contributing to the controversy surrounding this proposed schizophrenia marker.

Main Methods:

  • Utilized a filtration binding assay to assess 3H-spiroperidol binding to lymphocytes.
  • Investigated potential pitfalls such as unspecific filter binding and granulocyte contamination.
  • Compared different mathematical methods for data analysis due to atypical saturation curves.

Related Experiment Videos

Main Results:

  • Identified uncontrolled methodological issues, including unspecific filter binding (exacerbated by (+)-butaclamol) and variable granulocyte contamination, as contributors to controversy.
  • Observed an atypically shaped saturation curve, requiring comparative analysis using various mathematical approaches.
  • The findings highlight critical factors influencing the reliability of 3H-spiroperidol binding as a marker.

Conclusions:

  • Methodological limitations and uncontrolled variables significantly impact the interpretation of 3H-spiroperidol binding data in lymphocytes.
  • Addressing these pitfalls is crucial for accurately assessing the biological relevance of lymphocyte 3H-spiroperidol binding as a potential schizophrenia marker.
  • Further research with rigorous methodological control is needed to clarify the role of this marker in schizophrenia.